Autonomix Medical, Inc. Common Stock (AMIX) - Total Liabilities
Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has total liabilities worth $818.00K USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See AMIX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Autonomix Medical, Inc. Common Stock - Total Liabilities Trend (2022–2026)
This chart illustrates how Autonomix Medical, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Autonomix Medical, Inc. Common Stock asset portfolio.
Autonomix Medical, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wi2Wi Corporation
V:YTY
|
Canada | CA$5.74 Million |
|
CCH Holdings Ltd Ordinary Shares
NASDAQ:CCHH
|
USA | $7.60 Million |
|
EVE Health Group Limited
AU:EVE
|
Australia | AU$307.63K |
|
Movinn AS
CO:MOVINN
|
Denmark | Dkr33.67 Million |
|
Madoro Metals Corp
V:MDM
|
Canada | CA$62.26K |
|
iDimension Consolidated Bhd
KLSE:0174
|
Malaysia | RM119.71 Million |
|
Euroespes S.A.
MC:EEP
|
Spain | €5.22 Million |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
India | Rs381.79 Million |
Liability Composition Analysis (2022–2026)
This chart breaks down Autonomix Medical, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Autonomix Medical, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Autonomix Medical, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Autonomix Medical, Inc. Common Stock (2022–2026)
The table below shows the annual total liabilities of Autonomix Medical, Inc. Common Stock from 2022 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | $1.71 Million | -0.12% |
| 2025-03-31 | $1.71 Million | -4.05% |
| 2024-03-31 | $1.78 Million | +704.98% |
| 2023-03-31 | $221.00K | +137.02% |
| 2022-03-31 | $93.24K | -- |
About Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more